GROUP ONE TRADING, L.P. - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 149 filers reported holding ASCENDIS PHARMA A/S in Q1 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$266,312
+76.6%
2,844
+130.3%
0.00%
Q4 2022$150,831
-91.6%
1,235
-92.9%
0.00%
-100.0%
Q3 2022$1,793,000
+219.0%
17,365
+187.3%
0.00%
+300.0%
Q2 2022$562,000
+56100.0%
6,044
+54845.5%
0.00%
Q2 2021$1,000
-96.7%
11
-95.2%
0.00%
Q1 2021$30,000
-80.9%
231
-75.5%
0.00%
Q4 2020$157,000
+145.3%
941
+65.4%
0.00%
-100.0%
Q1 2020$64,000
-74.3%
569
-68.2%
0.00%
-50.0%
Q4 2019$249,000
+111.0%
1,788
+46.2%
0.00%
+100.0%
Q3 2019$118,000
-81.8%
1,223
-78.2%
0.00%
-83.3%
Q2 2019$647,000
+670.2%
5,615
+317.5%
0.01%
+500.0%
Q4 2018$84,000
+1100.0%
1,345
+1272.4%
0.00%
Q2 2018$7,000980.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2020
NameSharesValueWeighting ↓
Vivo Capital, LLC 2,046,832$240,912,00024.02%
RA Capital Management 4,132,442$486,388,00020.97%
VHCP Management II, LLC 504,210$59,346,00017.36%
Ghost Tree Capital, LLC 385,000$45,315,00011.84%
Sofinnova Investments, Inc. 998,538$117,528,00011.33%
Foresite Capital Management IV, LLC 245,424$28,886,00010.38%
Avoro Capital Advisors LLC 1,795,000$211,272,0009.14%
Orbimed Advisors 3,970,673$467,348,0007.24%
Eventide Asset Management 1,698,648$199,931,0006.88%
Foresite Capital Management III, LLC 204,088$24,021,0006.25%
View complete list of ASCENDIS PHARMA A/S shareholders